Sep 9, 20211 min readEducate your patients on IMBRUVICA treatment for CLL/SLL: A case-based approach ~ 9/22/21 @ 6pmMore details in attached flyer.Invite_JBI-01273_092221.pdfDownload PDF • 1.37MB
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
Commentaires